Literature DB >> 33028669

Multiregion whole-exome sequencing of intraductal papillary mucinous neoplasms reveals frequent somatic KLF4 mutations predominantly in low-grade regions.

Kohei Fujikura1, Waki Hosoda1,2, Matthäus Felsenstein1,3, Qianqian Song4, Johannes G Reiter5, Lily Zheng6, Violeta Beleva Guthrie7, Natalia Rincon8, Marco Dal Molin9, Jonathan Dudley9, Joshua D Cohen9, Pei Wang4, Catherine G Fischer1, Alicia M Braxton1, Michaël Noë1, Martine Jongepier1, Carlos Fernández-Del Castillo10, Mari Mino-Kenudson11, C Max Schmidt12, Michele T Yip-Schneider12, Rita T Lawlor13, Roberto Salvia14, Nicholas J Roberts1, Elizabeth D Thompson1, Rachel Karchin8, Anne Marie Lennon15, Yuchen Jiao16, Laura D Wood17.   

Abstract

OBJECTIVE: Intraductal papillary mucinous neoplasms (IPMNs) are non-invasive precursor lesions that can progress to invasive pancreatic cancer and are classified as low-grade or high-grade based on the morphology of the neoplastic epithelium. We aimed to compare genetic alterations in low-grade and high-grade regions of the same IPMN in order to identify molecular alterations underlying neoplastic progression.
DESIGN: We performed multiregion whole exome sequencing on tissue samples from 17 IPMNs with both low-grade and high-grade dysplasia (76 IPMN regions, including 49 from low-grade dysplasia and 27 from high-grade dysplasia). We reconstructed the phylogeny for each case, and we assessed mutations in a novel driver gene in an independent cohort of 63 IPMN cyst fluid samples.
RESULTS: Our multiregion whole exome sequencing identified KLF4, a previously unreported genetic driver of IPMN tumorigenesis, with hotspot mutations in one of two codons identified in >50% of the analyzed IPMNs. Mutations in KLF4 were significantly more prevalent in low-grade regions in our sequenced cases. Phylogenetic analyses of whole exome sequencing data demonstrated diverse patterns of IPMN initiation and progression. Hotspot mutations in KLF4 were also identified in an independent cohort of IPMN cyst fluid samples, again with a significantly higher prevalence in low-grade IPMNs.
CONCLUSION: Hotspot mutations in KLF4 occur at high prevalence in IPMNs. Unique among pancreatic driver genes, KLF4 mutations are enriched in low-grade IPMNs. These data highlight distinct molecular features of low-grade and high-grade dysplasia and suggest diverse pathways to high-grade dysplasia via the IPMN pathway. © Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  molecular genetics; mutations; pancreatic cancer; pancreatic pathology; pancreatic tumours

Mesh:

Substances:

Year:  2020        PMID: 33028669      PMCID: PMC8262510          DOI: 10.1136/gutjnl-2020-321217

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  49 in total

1.  851 resected cystic tumors of the pancreas: a 33-year experience at the Massachusetts General Hospital.

Authors:  Nakul P Valsangkar; Vicente Morales-Oyarvide; Sarah P Thayer; Cristina R Ferrone; Jennifer A Wargo; Andrew L Warshaw; Carlos Fernández-del Castillo
Journal:  Surgery       Date:  2012-07-06       Impact factor: 3.982

2.  A Revised Classification System and Recommendations From the Baltimore Consensus Meeting for Neoplastic Precursor Lesions in the Pancreas.

Authors:  Olca Basturk; Seung-Mo Hong; Laura D Wood; N Volkan Adsay; Jorge Albores-Saavedra; Andrew V Biankin; Lodewijk A A Brosens; Noriyoshi Fukushima; Michael Goggins; Ralph H Hruban; Yo Kato; David S Klimstra; Günter Klöppel; Alyssa Krasinskas; Daniel S Longnecker; Hanno Matthaei; G Johan A Offerhaus; Michio Shimizu; Kyoichi Takaori; Benoit Terris; Shinichi Yachida; Irene Esposito; Toru Furukawa
Journal:  Am J Surg Pathol       Date:  2015-12       Impact factor: 6.394

3.  Recurrent SETBP1 mutations in atypical chronic myeloid leukemia.

Authors:  Rocco Piazza; Simona Valletta; Nils Winkelmann; Sara Redaelli; Roberta Spinelli; Alessandra Pirola; Laura Antolini; Luca Mologni; Carla Donadoni; Elli Papaemmanuil; Susanne Schnittger; Dong-Wook Kim; Jacqueline Boultwood; Fabio Rossi; Giuseppe Gaipa; Greta P De Martini; Paola Francia di Celle; Hyun Gyung Jang; Valeria Fantin; Graham R Bignell; Vera Magistroni; Torsten Haferlach; Enrico Maria Pogliani; Peter J Campbell; Andrew J Chase; William J Tapper; Nicholas C P Cross; Carlo Gambacorti-Passerini
Journal:  Nat Genet       Date:  2012-12-09       Impact factor: 38.330

4.  Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO.

Authors:  Victoria E Clark; E Zeynep Erson-Omay; Akdes Serin; Jun Yin; Justin Cotney; Koray Ozduman; Timuçin Avşar; Jie Li; Phillip B Murray; Octavian Henegariu; Saliha Yilmaz; Jennifer Moliterno Günel; Geneive Carrión-Grant; Baran Yilmaz; Conor Grady; Bahattin Tanrikulu; Mehmet Bakircioğlu; Hande Kaymakçalan; Ahmet Okay Caglayan; Leman Sencar; Emre Ceyhun; A Fatih Atik; Yaşar Bayri; Hanwen Bai; Luis E Kolb; Ryan M Hebert; S Bulent Omay; Ketu Mishra-Gorur; Murim Choi; John D Overton; Eric C Holland; Shrikant Mane; Matthew W State; Kaya Bilgüvar; Joachim M Baehring; Philip H Gutin; Joseph M Piepmeier; Alexander Vortmeyer; Cameron W Brennan; M Necmettin Pamir; Türker Kiliç; Richard P Lifton; James P Noonan; Katsuhito Yasuno; Murat Günel
Journal:  Science       Date:  2013-01-24       Impact factor: 47.728

5.  Induction of pluripotent stem cells from adult human fibroblasts by defined factors.

Authors:  Kazutoshi Takahashi; Koji Tanabe; Mari Ohnuki; Megumi Narita; Tomoko Ichisaka; Kiichiro Tomoda; Shinya Yamanaka
Journal:  Cell       Date:  2007-11-30       Impact factor: 41.582

6.  Secretory meningiomas are defined by combined KLF4 K409Q and TRAF7 mutations.

Authors:  David E Reuss; Rosario M Piro; David T W Jones; Matthias Simon; Ralf Ketter; Marcel Kool; Albert Becker; Felix Sahm; Stefan Pusch; Jochen Meyer; Christian Hagenlocher; Leonille Schweizer; David Capper; Phillipp Kickingereder; Jana Mucha; Christian Koelsche; Natalie Jäger; Thomas Santarius; Patrick S Tarpey; Philip J Stephens; P Andrew Futreal; Ruth Wellenreuther; Jürgen Kraus; Doris Lenartz; Christel Herold-Mende; Christian Hartmann; Christian Mawrin; Nathalia Giese; Roland Eils; V Peter Collins; Rainer König; Otmar D Wiestler; Stefan M Pfister; Andreas von Deimling
Journal:  Acta Neuropathol       Date:  2013-02-12       Impact factor: 17.088

7.  Pathways of Progression From Intraductal Papillary Mucinous Neoplasm to Pancreatic Ductal Adenocarcinoma Based on Molecular Features.

Authors:  Yuko Omori; Yusuke Ono; Mishie Tanino; Hidenori Karasaki; Hiroshi Yamaguchi; Toru Furukawa; Katsuro Enomoto; Jun Ueda; Atsuko Sumi; Jin Katayama; Miho Muraki; Kenzui Taniue; Kuniyuki Takahashi; Yoshiyasu Ambo; Toshiya Shinohara; Hiroshi Nishihara; Junpei Sasajima; Hiroyuki Maguchi; Yusuke Mizukami; Toshikatsu Okumura; Shinya Tanaka
Journal:  Gastroenterology       Date:  2018-10-17       Impact factor: 22.682

8.  Prevalence of unsuspected pancreatic cysts on MDCT.

Authors:  Thomas A Laffan; Karen M Horton; Alison P Klein; Bruce Berlanstein; Stanley S Siegelman; Satomi Kawamoto; Pamela T Johnson; Elliot K Fishman; Ralph H Hruban
Journal:  AJR Am J Roentgenol       Date:  2008-09       Impact factor: 3.959

9.  Klf4 is a transcriptional regulator of genes critical for EMT, including Jnk1 (Mapk8).

Authors:  Neha Tiwari; Nathalie Meyer-Schaller; Phil Arnold; Helena Antoniadis; Mikhail Pachkov; Erik van Nimwegen; Gerhard Christofori
Journal:  PLoS One       Date:  2013-02-25       Impact factor: 3.240

10.  Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples.

Authors:  Kristian Cibulskis; Michael S Lawrence; Scott L Carter; Andrey Sivachenko; David Jaffe; Carrie Sougnez; Stacey Gabriel; Matthew Meyerson; Eric S Lander; Gad Getz
Journal:  Nat Biotechnol       Date:  2013-02-10       Impact factor: 54.908

View more
  11 in total

1.  Estimation of cancer cell fractions and clone trees from multi-region sequencing of tumors.

Authors:  Lily Zheng; Noushin Niknafs; Laura D Wood; Rachel Karchin; Robert B Scharpf
Journal:  Bioinformatics       Date:  2022-06-01       Impact factor: 6.931

Review 2.  Pancreatic Cancer: Pathogenesis, Screening, Diagnosis, and Treatment.

Authors:  Laura D Wood; Marcia Irene Canto; Elizabeth M Jaffee; Diane M Simeone
Journal:  Gastroenterology       Date:  2022-04-07       Impact factor: 33.883

Review 3.  Current Pathology Model of Pancreatic Cancer.

Authors:  Krzysztof Szymoński; Katarzyna Milian-Ciesielska; Ewelina Lipiec; Dariusz Adamek
Journal:  Cancers (Basel)       Date:  2022-05-07       Impact factor: 6.575

Review 4.  Early detection of pancreatic cancer using DNA-based molecular approaches.

Authors:  Aatur D Singhi; Laura D Wood
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-06-07       Impact factor: 46.802

Review 5.  The biology of pancreatic cancer morphology.

Authors:  Oliver G McDonald
Journal:  Pathology       Date:  2021-12-03       Impact factor: 5.306

6.  Downregulation of 5-hydroxymethylcytosine is an early event in pancreatic tumorigenesis.

Authors:  Kohei Fujikura; Zainab I Alruwaii; Michael C Haffner; Maria A Trujillo; Nicholas J Roberts; Seung-Mo Hong; Anne Macgregor-Das; Michael G Goggins; Sujayita Roy; Alan K Meeker; Ding Ding; Michael Wright; Jin He; Ralph H Hruban; Laura D Wood
Journal:  J Pathol       Date:  2021-05-21       Impact factor: 9.883

7.  Pancreatic cancer driver mutations are targetable through distant alternative RNA splicing dependencies.

Authors:  Ryan R Kawalerski; Steven D Leach; Luisa F Escobar-Hoyos
Journal:  Oncotarget       Date:  2021-03-16

Review 8.  Case report: composite pancreatic intraductal papillary mucinous neoplasm and neuroendocrine tumor: a new mixed neuroendocrine-non-neuroendocrine neoplasm?

Authors:  Jingci Chen; Pengyan Wang; Ke Lv; Weixun Zhou
Journal:  Diagn Pathol       Date:  2021-11-20       Impact factor: 2.644

Review 9.  Pancreatic cancer pathology viewed in the light of evolution.

Authors:  Michaël Noë; Seung-Mo Hong; Laura D Wood; Elizabeth D Thompson; Nicholas J Roberts; Michael G Goggins; Alison P Klein; James R Eshleman; Scott E Kern; Ralph H Hruban
Journal:  Cancer Metastasis Rev       Date:  2021-02-08       Impact factor: 9.237

Review 10.  Pathology of intraductal papillary mucinous neoplasms.

Authors:  Naziheh Assarzadegan; Elizabeth Thompson; Kevan Salimian; Matthias M Gaida; Lodewijk A A Brosens; Laura Wood; Syed Z Ali; Ralph H Hruban
Journal:  Langenbecks Arch Surg       Date:  2021-05-28       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.